Rohto Dry Aid: providing effective relief for up to 12 hours
In a four-week clinical study, Rohto Dry Aid was proven to significantly improve ocular discomfort and be long lasting

Rohto Dry Aid: providing effective relief for up to 12 hours

August 6, 2024 Sponsored feature

Rohto Dry Aid (RDA) relieves eights symptoms of dry eye – itchiness, dryness, soreness, irritation, burning, grittiness, stinging and tiredness. Operating as eyecare specialists since 1909 and recognised as the number one eyecare brand in Japan, RDA hydrates, restores and protects, providing soothing and effective relief for up to 12 hours.

 

Almost six out of 10 adults now suffer from dry eye disease (DED)1. Unfortunately, most people are unaware they suffer from this condition and don’t know what symptoms to look out for. The main symptoms of DED include watery, itchy, gritty, burning, sore, tired, irritated, stinging and blurry eyes, difficulty opening the eyes, light sensitivity or just really, really dry eyes.

 

It is common for dry eye sufferers to experience a combination of both types of dry eye2: aqueous, where the tear glands don’t produce enough tears; and evaporative, making up 85% of dry eye cases3, caused by a damaged tear film lipid layer which increases tear evaporation. RDA is unique to the already available eye drops as it works on BOTH types, making it easier to recommend a suitable dry eye relief drop to patients.

 

With the right management, dry eye can be improved and its symptoms relieved.

 

The innovative Tearshield Technology formulation combines ingredients which target all layers of the tear film, aiming to end the vicious cycle of dry eye. The unique lipid-enhancing formulation is particularly effective for evaporative dry eye as it enhances the thickness of the lipid layer and the spread, stabilising the tear film and restoring its natural function – breaking the cycle of dry eye effectively.

 

In a four-week clinical study4, Rohto Dry Aid was proven to significantly improve ocular discomfort and to be long lasting:

 

Graph 1. Symptoms reduced over 29 days of continuous use

 

Dry Eye sufferers may experience more than one symptom without knowing what it could be. If left untreated, the dry eye cycle continues and, with time, it can cause severe damage to the surface of the eye and impact quality of life. Rohto Dry Aid is effective for, but not limited to:

 

  • Digital screen users – intensive use of screens causes eye strain, less blinking and dryness
  • Menopausal women – during and after menopause, hormonal changes cause tear production to decrease, or in some instances, increased tear evaporation may also occur
  • Adults over the age of 50 – as we get older, tear production and the quality of tears decrease, meaning dry eye symptoms with age are likely to occur.

 

RDA works on all layers of the tear film and uses helpful ingredients such as sesame oil, polyoxyl sterate, menthol and polyoxyethylene castor oil to restore the lipid and muco-aqueous layers. Trials have confirmed that overall, RDA’s formulation reduces tear evaporation and extends dry eye symptom relief by increasing tear film breakup time (TFBUT). After trialling Rohto Dry Aid eye drops5, it was also found that:

  • 94% of users said it soothed and hydrated their eyes effectively
  • 97% said symptoms were relieved in two minutes or less
  • 84% said it provided all day symptom relief
  • 97% found Rohto Dry Aid easy to use
  • 93% confirmed their vision was not blurry

 

Sesame oil has a very similar physical property to meibum. Rohto’s research demonstrated that the sesame oil in RDA drops mixes and spreads homogenously with lipid layer compounds, proving its effectiveness in evaporative dry eye. For more scan the QR code:

 

 

For more on how the menthol in RDA’s formulation helps mimic the lipid layer structure, increase the lipid layer’s stability and enhance the upward spread of the tear film and thus tear film stability, scan the following QR code:

 

 

References

  1. Global Perspectus, Summer 2022; 1,109 nationally representative consumers questioned
  2. https://pubmed.ncbi.nlm.nih.gov/28736340
  3. www.ncbi.nlm.nih.gov/pmc/articles/PMC6202299
  4. Clin Ophthalmol 2017:111883-1889’ Originally published by, adapted and used with permission from Dove Medical Press Ltd
  5. Data on file
  6. INTAGE certificate number 2303367 18 Jan 2024

 

OphthalmoPro is the exclusive distributor of Rohto Dry Aid in New Zealand.

 

For enquiries, please contact +64 274 303 093 or orders@ophthalmopro.com.au.